Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
MR Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
It is essential to know intestinal length and anastomotic type in post-operative short bowel syndrome patients. These parameters can help predict long-term intestinal failure with long-term parenteral nutrition usually needed for smallest lengths. Sometimes these parameters are unfortunately missing for lack of intraoperative measurement. Thus, it is necessary to develop non-invasive and reproducible techniques to assess small bowel length. This is the reason why the investigators will evaluate magnetic resonance (MR)-enterography and barium follow-through in this indication. There are at this time only two small studies evaluating barium follow-through for intestinal length measurement, and none evaluating MR-enterography. However, a major advantage of the latter is the lack of radiation exposure and possibility to perform 3D. This will be an open labelled single center crossover study. Short bowel syndrome patients of the investigators center will be included after consent. The sequence of exams (MR enterography followed by barium follow-through or vice-versa) will be randomly assigned. Peroperative short bowel length measurement will be available for all patients. There will be one month between the two exams. The main objective of this study is to assess the performance of MR-enterography in short bowel measurement in short bowel syndrome patients, the gold standard being peroperative length. Secondary objectives are to assess the performance of barium follow-through in short bowel measurement in these patients, and to show that barium follow-through does not perform better than MR-enterography. For that purpose the investigators will include 50 patients over 2 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 2, 2010
CompletedFirst Posted
Study publicly available on registry
August 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedAugust 18, 2010
June 1, 2010
3 months
August 2, 2010
August 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test
at 3 months
Secondary Outcomes (1)
Assessment of the lack of difference between surgical and barium follow through small bowel length measurement with a comparison sample test
at 3 months
Study Arms (2)
Bras pair
OTHERMR-enterography then barium follow through
Bras impair
OTHERBarium follow-through then MR-enterography
Interventions
Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test
Eligibility Criteria
You may qualify if:
- Intraoperative small bowel length \< 200 cm
- Males and females between 18 and 85 years of age
- Patient with social insurance
- Signature of informed consent
You may not qualify if:
- Allergy to contrast product
- Enterostomy closure expected within 2 months after randomization
- Pregnancy or breast feeding woman
- Swallowing disorders
- Deprivation of liberty
- Contraindications to magnetic resonance imaging (pace-maker, metal implant, known allergy to gadolinium)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service d'Hépato-Gastroentérologie et Nutrition Clinique - CHU Nice - hôpital Archet 2
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SCHNEIDER Stephane, PU-PH
Services d'Hépato-Gastroentérologie et Nutrition Clinique
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 2, 2010
First Posted
August 18, 2010
Study Start
July 1, 2010
Primary Completion
October 1, 2010
Study Completion
July 1, 2012
Last Updated
August 18, 2010
Record last verified: 2010-06